第一金融网主办
»您现在的位置: 第一金融网 >> 金融焦点 >> 文传商讯 >> 正文

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 2017

2017/8/22 8:01:42  文章来源:文传商讯  作者:文传商讯
文章简介: NewdatatobepresentedwillinformphysiciansondifferentaspectsoftreatmentforpatientswithatrialfibrillationResultsofRE-DUALPCItrialwillbepres

New data to be presented will inform physicians on different aspects of treatment for patients with atrial fibrillation Results of RE-DUAL PCI trial will be presented in ‘Late Breaking Science in PCI 2’ session on 27 August1

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress.The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke prevention in atrial fibrillation and are therefore approved around the world in this indication.1

“The presentation of the results of our RE-DUAL PCI™ trial at ESC is particularly timely as the focus of the 2017 congress is ‘40 years of PCI’”, commented Professor Jörg Kreuzer, Vice President Medicine, Therapeutic Area Cardiovascular, Boehringer Ingelheim. “We are honoured that the results will be included in the congress Spotlight Session and hope that the findings from the trial will provide a valuable contribution to patient management in the PCI setting.”

Details of the data presented at the ESC 2017 are as follows:

Abstract Title   Details

(Venue: Fira Gran Via, Barcelona)

 
RE-DUAL PCI™: Dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibrillation1   ‘Late-breaking Science in PCI 2’ Spotlight of the Congress (1920), 14:45-15:00, 27 August, Spotlight Stage, Speaker Christopher Cannon  
Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey2   ‘Poster session 4: Stroke prevention’ (P3618), 08:30-12:30, 28 August, Poster Area, Speaker Deidre Lane  
Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF™ Registry3   ‘Poster session 5: Registries and cost of treatment’ (P4600) 14:00-18:00, 28 August, Poster Area, Speaker Gregory Lip  
Development and validation of a novel biomarker-based risk score to improve the prediction of death in patients with atrial fibrillation4   ‘Stroke risk prediction in atrial fibrillation’ session (5770), 14:54-15:12, 29 August, Valetta – Village 5, Speaker Ziad Hijazi  
 

分享到:
第一金融网免责声明:
1、本网站中的文章(包括转贴文章)的版权仅归原作者所有,若作者有版权声明的或文章从其它网站转载而附带有原所有站的版权声明者,其版权归属以附带声明为准。
2、文章来源为均为其它媒体的转载文章,我们会尽可能注明出处,但不排除来源不明的情况。转载是处于提供必发88客户端信息以参考使用或学习、交流、科研之目的,不用于 商业用途。转载无意侵犯版权,如转载文章涉及您的权益等问题,请作者速来电话和函告知,我们将尽快处理。来信:fengyueyoubian#sina.com (请将#改为@)。
3、本网站所载文章、数据、网友投稿等内容纯属作者个人观点,仅供投资者参考,并不构成投资建议,与第一金融网站无关。投资者据此操作,风险自担。如对本文内容有疑义,请及时与我们联系。
发表评论

【发表评论】(网友评论内容只代表网友观点,与本站立场无关!)
 姓 名:
 评 分: 1分 2分 3分 4分 5分
 评论内容:
验证码:   *
  • 请遵守《互联网电子公告服务管理规定》及中华人民共和国其他各项有关法律法规。
  • 严禁发表危害国家安全、损害国家利益、破坏民族团结、破坏国家宗教政策、破坏社会稳定、侮辱、诽谤、教唆、淫秽等内容的评论 。
  • 用户需对自己在使用本站服务过程中的行为承担法律责任(直接或间接导致的)。
  • 本站管理员有权保留或删除评论内容。
  • 评论内容只代表网友个人观点,与本网站立场无关。
  • 全站精选
    [新闻]  大发现!朝鲜发现高丽王陵(图)被认定为第15代
     吐槽医院食堂饭菜难吃被拘,警示权力不可任性
    [银行]  银监会:着力防范影子银88必发官方手机登录务风险
     2017银行存款最新利率 上浮是假缩水是真!
    [股票]  质押乐视网获11亿“小钱”?孙宏斌咋想的
     腾讯京东阿里被传密会乐视 乐视称不排除引入新投
    [基金]  中国私募基金规模逼近10万亿大关:今年已累计增
     基金经理论市:金融板块逆市上涨是避险情绪的反
    [保险]  中国保监会印发《信用保证保险业务监管暂行办法
     《保险业务要素数据规范》发布
    [期货]  期货疯狂 黑色系再现涨停潮
     国际油价难超40美元地板价 国内成品油价短期锁死
    [股评]  机构预测明日大盘走势(8/22)
     周二机构一致最看好的十大金股(8/22)
    [港股]  腾讯急升5.3% 带动恒指高开201点
     万达旗下AMC院线股价今年已累计下跌57%
    [美股]  微博回应被立案调查:配合调查 积极整改
     谷歌发薪性别歧视 逾60女员工拟起诉
    [外汇]  知情人士:中国央行拟调整人民币中间价形成机制
     央行突施"紧箍咒"  当心这几个利空
    [债券]  工行新闻发言人:没有抛售客户债券 有人过度解读
     瑞银:中国债券市场规模5年内将超越日本成全球第
    [黄金]  互金协会禁令:禁止以“创始会员”名义宣传
     黄金热下的黑平台骗局:宣称百分百盈利 诱使客户
    [理财]  《战狼2》票房破50亿 吴京《战狼3》肯定要拍
     恭喜!王思聪前女友雪梨承认怀孕 曾与富二代订婚
    [信托]  乐视网称与民生信托达成和解:乐视系12亿资产冻
     华宸信托员工诈骗两年无人察觉 7500多万挥霍一空
    [房产]  前七月北京新房销售面积下降40%,“最严厉”调控
     非京籍买共有产权房可落户北京? 专家:系误读
    [汽车]  吉利远景X3将8月25日上市 预售5.59-7.39万
     马自达大七座SUV-CX-9实车曝光 首搭2.5T引擎
  • 此栏目下没有推荐文章
  • | 设为首页 | 加入收藏 | 关于我们 | 友情链接 | 版权申明 | 文章列表 | 网站地图 | 征稿启事 | 广告服务 | 意见反馈 |

    Copyright©2006-2017 afinance.cn All Rights Reserved 版权所有·第一金融网 ,未经授权禁止复制或建立镜像,否则将依法追究法律责任!

    声明:我们不做任何形式的代客理财及投资指导,凡是以第一金融网名义做股票推荐的行为均属违法!

    广告商的言论与行为均与第一金融网无关!股市有风险,投资需谨慎。

    合作邮箱:fengyueyoubian@sina.com 合作电话:18678839953 点击这里给我发消息

    博聚网